SCHEMBL9343956

SCHEMBL9343956

CCOC(=O)C(N)Cc1cc(CP(=O)(OCC)OCC)cc(-c2ccc(Cl)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MME P08473 3/20 0.38
▸ TPH1 P17752 2/20 0.36
▸ MLNR O43193 1/20 0.36
▸ NR3C1 P04150 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ AGTR1 P30556 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ CCKAR P32238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348521 0.93 MEN1 (0.39) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9345597 0.90 MEN1 (0.50) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9345173 0.90 KMT2A (0.40) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9344786 0.89 MEN1 (0.43) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9348888 0.85 MEN1 (0.41) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9348882 0.85 MEN1 (0.41) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9343960 0.79 MEN1 (0.52) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL9345135 0.77 MEN1 (0.56) TDP1MEN1ALOX15CYP2C19KMT2A
SCHEMBL21117877 0.75 EPHX2 (0.51) CYP2C19MAPTALDH1A1LMNASLC6A2
SCHEMBL2734222 0.75 EPHX2 (0.51) CYP2C19MAPTALDH1A1LMNASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5321016-A Epliepsy, central nervous system disorders SANDOZ PHARMACEUTICALS CORP. (US) 1994-06-14 — — US disclosed
Send feedback